Results

Total Results: over 10,000 records

Showing results for "drug".

41. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - /class, time between drug initiation and start of drug holiday, duration of drug holiday, post-drug … (pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration of … : pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration … of drug holiday, post-drug holiday agent/class Continued osteoporosis drug treatment after >1 yr … characteristics: pre-drug holiday agent/class, time between drug initiation and start of drug holiday

42. Reduced effectiveness of interruptive drug–drug interaction alerts after conversion to a commercial electronic health record. | PSNet
    psnet.ahrq.gov/issue/reduced-effectiveness-interruptive-drug-drug-interaction-alerts-after-conversion-commercial
    May 20, 2019 - Study Reduced effectiveness of interruptive drug–drug interaction alerts after conversion … Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic … transition from a legacy electronic health record system to a commercial system on provider reactions to drug–drug … Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic … Related Resources From the Same Author(s) Structured override reasons for drug–drug

43. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey. | PSNet
    psnet.ahrq.gov/issue/overall-performance-drug-drug-interaction-clinical-decision-support-system-quantitative
    August 10, 2022 - Study Overall performance of a drug-drug interaction clinical decision support system … Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation … Clinical decision support systems (CDSS) can help identify potential drug-drug interactions (DDI), but … Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation … August 10, 2022 High-priority drug-drug interaction clinical decision support overrides

44. Drug-related hospital admissions. | PSNet
    psnet.ahrq.gov/issue/drug-related-hospital-admissions
    September 07, 2016 - Study Classic Drug-related hospital admissions. … Citation Text: Drug-related hospital admissions. … This systematic review summarizes reported rates of drug-related hospital admissions from 36 different … The findings suggest that approximately 5% of all admissions are attributable to adverse drug reactions … June 23, 2010 Potential for drug interactions in hospitalized cancer patients.

45. Reducing Adverse Drug Events. | PSNet
    psnet.ahrq.gov/issue/reducing-adverse-drug-events
    August 09, 2017 - Book/Report Classic Reducing Adverse Drug Events. … Citation Text: Reducing Adverse Drug Events. Leape LL, Kabcenell A, Berwick DM et al. … Institute for Healthcare Improvement (IHI) Breakthrough Series program focusing on decreasing adverse drug … Copy URL Cite Citation Citation Text: Reducing Adverse Drug … Providers Health Care Executives and Administrators Pharmacy Medication Errors/Preventable Adverse Drug

46. Medication/Drug Errors | PSNet
    psnet.ahrq.gov/curated-library/medicationdrug-errors
    March 12, 2021 - Home The PSNet Collection Curated Libraries Subscribed Medication/Drug … This Library reflects a curated selection of PSNet content focused on medication and drug errors. … Ther Adv Drug Saf . 2016; 7 (3) :102-119 . … Evaluation and Research, US Food and Drug Administration; April 2016. … This Web site provides information for providers and patients to reduce risks related to adverse drug

47. Drug Safety | CDS Connect
    cds.ahrq.gov/cdsconnect/keywords/drug-safety
    August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

48. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. | PSNet
    psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998-2005
    June 07, 2016 - Study Serious adverse drug events reported to the Food and Drug Administration, 1998 … Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … Voluntarily reported  adverse drug events increased markedly from 1998-2005, with a small proportion … Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … event reports received by the US Food and Drug Administration in 2014.

49. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002. | PSNet
    psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969-2002
    October 08, 2014 - Study Adverse drug event surveillance and drug withdrawals in the United States, … Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance … Food and Drug Administration (FDA). … Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance … Counterfeit drug prevention and identification.

50. Medicare Prescription Drug Coverage | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/medicare-prescription-drug-coverage

51. Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant Drug-Drug Interactions | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/implementation-ddinteract-shared-decision-making-tool-anticoagulant-drug-drug
    August 15, 2023 - Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant Drug-Drug Interactions … Project Description This research has the potential to reduce drug-drug … have additional comorbidities requiring other medications, which increases the risk of bleeding due to drug-drug … cluster randomized, multisystem trial to evaluate the effectiveness of DDInteract to mitigate exposure to drug … The research will also include an expert panel with recognized expertise in implementation science, drug

52. Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/overriding
    January 01, 2023 - Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. … Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. … Project Name Meaningful Drug Interaction Alerts Technology Clinical Decision Support

53. Analysis of overridden alerts in a drug–drug interaction detection system. | PSNet
    psnet.ahrq.gov/issue/analysis-overridden-alerts-drug-drug-interaction-detection-system
    June 30, 2011 - Study Analysis of overridden alerts in a drug–drug interaction detection system. … Analysis of overridden alerts in a drug-drug interaction detection system. … Analysis of overridden alerts in a drug-drug interaction detection system. … RIS Download Citation Related Resources From the Same Author(s) Drug … November 29, 2023 Drug related problems and pharmacist interventions in a geriatric unit

54. Incidence of adverse drug events and potential adverse drug events: implications for prevention. | PSNet
    psnet.ahrq.gov/issue/incidence-adverse-drug-events-and-potential-adverse-drug-events-implications-prevention
    February 10, 2011 - Study Classic Incidence of adverse drug events and potential … adverse drug events: implications for prevention. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … February 10, 2011 Systems analysis of adverse drug events.

55. Optimization of drug–drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard. | PSNet
    psnet.ahrq.gov/issue/optimization-drug-drug-interaction-alert-rules-pediatric-hospitals-electronic-health-record
    May 20, 2019 - Study Optimization of drug–drug interaction alert rules in a pediatric hospital's … Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record … Researchers used rapid-cycle iterative interventions to improve drug interaction alerts by eliminating … Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record … Related Resources From the Same Author(s) Structured override reasons for drug–drug

56. Drug-drug interactions and actual harm to hospitalized patients: a multicentre study examining the prevalence pre- and post-electronic medication system implementation. | PSNet
    psnet.ahrq.gov/issue/drug-drug-interactions-and-actual-harm-hospitalized-patients-multicentre-study-examining
    August 26, 2020 - Study Drug-drug interactions and actual harm to hospitalized patients: a multicentre … Drug-drug interactions and actual harm to hospitalized patients: a multicentre study examining the prevalence … Drug Saf. 2024;47(6):557-569. doi:10.1007/s40264-024-01412-w. … Drug-drug interactions (DDI) can be harmful. … Drug-drug interactions and actual harm to hospitalized patients: a multicentre study examining the prevalence

57. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. | PSNet
    psnet.ahrq.gov/issue/hospital-admissions-due-adverse-drug-reactions-report-boston-collaborative-drug-surveillance
    March 01, 2023 - : a report from the Boston Collaborative Drug Surveillance Program. … Hospital admissions due to adverse drug reactions. … A report from the Boston Collaborative Drug Surveillance Program. … Hospital admissions due to adverse drug reactions. … A report from the Boston Collaborative Drug Surveillance Program.

58. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: override appropriateness and adverse drug events. | PSNet
    psnet.ahrq.gov/issue/high-priority-drug-drug-interaction-clinical-decision-support-overrides-newly-implemented
    March 09, 2022 - Study High-priority drug-drug interaction clinical decision support overrides in … High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial … This retrospective study evaluated over 16,000 alerts for drug-drug interactions and found that nearly … High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial … November 11, 2020 Overriding drug-drug interaction alerts in clinical decision support

59. Provider and pharmacist responses to warfarin drug–drug interaction alerts: a study of healthcare downstream of CPOE alerts. | PSNet
    psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts-study-healthcare
    July 29, 2020 - Study Provider and pharmacist responses to warfarin drug–drug interaction alerts: … Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream … the role of alert fatigue and provider overrides in contributing to warfarin -related adverse drug … Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream … September 1, 2016 A clinical case of electronic health record drug alert fatigue: consequences

60. Anticoagulation-associated adverse drug events. | PSNet
    psnet.ahrq.gov/issue/anticoagulation-associated-adverse-drug-events
    July 26, 2023 - Study Anticoagulation-associated adverse drug events. … Anticoagulation-associated Adverse Drug Events. … other anticoagulant medications place patients, especially elderly ones, at high risk of adverse drug … Anticoagulation-associated Adverse Drug Events. … July 26, 2023 Adverse drug events in hospitalized cardiac patients.